XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.2
Share Based Awards (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used to Calculate the Fair Value of Options Granted

The range of assumptions used to calculate the fair value of options granted during the six months ended June 30, 2025 was:

 

Exercise Price   $6.738.56  
Stock price on date of grant   6.738.46  
Risk-free interest rate   3.944.44 %
Dividend yield     
Expected term (years)   5.875.97  
Volatility   177.58191.15 %
Schedule of Options Activity

A summary of options activity under the Plan since December 31, 2024 was:

 

   Shares  

Weighted-

Average

Exercise

Price

  

Weighted-

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2024   5,645,325   $1.54    7.90   $59,779,836 
Granted   1,760,850    7.22           
Exercised   (1,875,862)   1.29           
Forfeited or expired   (213,253)   1.90           
Outstanding as of June 30, 2025   5,317,060    3.38    8.26    21,216,913 
Exercisable as of June 30, 2025   1,553,548   $1.33    5.54   $9,245,793 
Schedule of Restricted Stock Activity

A summary of restricted stock activity under the Plan since December 31, 2024 was:

 

   Shares   Weighted Average Grant-Date Fair Value Per Share 
Unvested and outstanding as of December 31, 2024   1,544,027   $3.84 
Granted   787,242    6.93 
Vested        
Forfeited   (321,428)   0.89 
Unvested and outstanding as of June 30, 2025   2,009,841   $5.53 
Schedule of Stock Compensation Expense by Functional Operating Expense

Stock compensation expense for the six months ended June 30 by functional operating expense was:

 

   2025   2024 
Research and development  $321,018   $267,459 
Sales and marketing   1,731,973    175,478 
General and administrative   1,581,042    1,321,105 
Total  $3,634,033   $1,764,042